Baxevanis, C.N.; Gritzapis, A.D.; Voutsas, I.F.; Batsaki, P.; Goulielmaki, M.; Adamaki, M.; Zoumpourlis, V.; Fortis, S.P.
T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker. Cancers 2022, 14, 2674.
https://doi.org/10.3390/cancers14112674
AMA Style
Baxevanis CN, Gritzapis AD, Voutsas IF, Batsaki P, Goulielmaki M, Adamaki M, Zoumpourlis V, Fortis SP.
T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker. Cancers. 2022; 14(11):2674.
https://doi.org/10.3390/cancers14112674
Chicago/Turabian Style
Baxevanis, Constantin N., Angelos D. Gritzapis, Ioannis F. Voutsas, Panagiota Batsaki, Maria Goulielmaki, Maria Adamaki, Vassilios Zoumpourlis, and Sotirios P. Fortis.
2022. "T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker" Cancers 14, no. 11: 2674.
https://doi.org/10.3390/cancers14112674
APA Style
Baxevanis, C. N., Gritzapis, A. D., Voutsas, I. F., Batsaki, P., Goulielmaki, M., Adamaki, M., Zoumpourlis, V., & Fortis, S. P.
(2022). T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker. Cancers, 14(11), 2674.
https://doi.org/10.3390/cancers14112674